Log in
Enquire now
‌

US Patent 8415469 Compounds and methods for kinase modulation, and indications therefor

Patent 8415469 was granted and assigned to Plexxikon Inc. on April, 2013 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Plexxikon Inc.
Plexxikon Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
84154690
Patent Inventor Names
Brian West0
Chao Zhang0
Dean R. Artis0
Gaston Habets0
Gideon Bollag0
Guoxian Wu0
Hanna Cho0
Hongyao Zhu0
...
Date of Patent
April 9, 2013
0
Patent Application Number
126160790
Date Filed
November 10, 2009
0
Patent Citations Received
‌
US Patent 12083112 Combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor for treating cancer
0
‌
US Patent 11925639 Tumor-treating pharmaceutical composition
0
‌
US Patent 12076322 Compounds and methods for kinase modulation, and indications therefor
0
Patent Primary Examiner
‌
Niloofar Rahmani
0
Patent abstract

Compounds active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8415469 Compounds and methods for kinase modulation, and indications therefor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.